Showing results (7271-7280 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|June 26, 2012
Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammationAnnalisa Marcuzzi, Sergio Crovella, Lorenzo Monasta, et al.Current Pharmaceutical Design|June 26, 2012
From bone marrow transplantation to cellular therapies: possible therapeutic strategies in managing autoimmune disordersAndrea Taddio, Andrea Biondi, Elisa Piscianz, et al.Current Pharmaceutical Design|August 17, 2012
β-lactam resistance in gram-negative pathogens isolated from animalsDarren TrottCurrent Pharmaceutical Design|August 17, 2012
Detection of gram-negative β-lactamase producing pathogens in the clinical labKenneth S ThomsonCurrent Pharmaceutical Design|August 17, 2012
The rise of carbapenem-resistant Acinetobacter baumanniiBenjamin A Evans, Ahmed Hamouda, Sebastian G B AmyesCurrent Pharmaceutical Design|July 1, 2014
Conventional anticancer therapeutics and telomere maintenance mechanismsOrit Uziel, Meir LahavCurrent Pharmaceutical Design|July 1, 2014
Telomerase modulation in therapeutic approachAleksandra Romaniuk, Przemyslaw Kopczynski, Krzysztof Ksiazek, et al.Current Pharmaceutical Design|July 1, 2014
Telomere recombination and the ALT pathway: a therapeutic perspective for cancerIrena Draskovic, Arturo Londono-VallejoCurrent Pharmaceutical Design|September 1, 2012
Nampt/Visfatin/PBEF: a functionally multi-faceted protein with a pivotal role in malignant tumorsHe Jieyu, Tu Chao, Li Mengjun, et al.Current Pharmaceutical Design|August 28, 2012
Lysosomal rerouting of Hsp70 trafficking as a potential immune activating tool for targeting melanomaKata Juhász, Roland Thuenauer, Andrea Spachinger, et al.Pageof 1,009